Biosynthesis of Selenium Nanoparticles by Ralstonia mannitolilytica and Evaluation of Their Antibacterial Activity
Iraqi Journal of Medical Sciences · 22.06.2026 · 24 (1) · 89-99
DOI: 10.22578/d2qjma08 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 22.06.2026. Verfasst von Rusul J. Dahee und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Using microorganisms such as Ralstonia mannitolilytica (R. mannitolilytica), to create selenium nanoparticles (SeNPs) offers a promising path for Grammy advancement. Antibiotic resistance poses a formidable challenge, particularly against multidrug-resistant (MDR) bacteria. The employment of supernatant as a cost-effective and straightforward approach enhances the efficacy of SeNPs biosynthesis.
Objective
To explore the biosynthesis of SeNPs by R. mannitolilytica with the aim of achieving cost-effective and environmentally friendly production methods while ensuring novel morphological characteristics of SeNPs furthermore evaluated of antimicrobial and toxicity.
Methods
Preparation SeNPs by biological method (Biosynthesis). Ultraviolet-visible spectrophotometer (UV–Vis), energy dispersive of X-ray spectroscopy (EDX), atomic force microscopic (AFM), X-ray diffraction (XRD), Zeta potential analysis (ZP); these methods were used to characterize the physical properties. The well diffusion assay and minimum inhibitory concentration (MIC) of 16 μg/ml were also assessed.
Results
This study successfully demonstrates the biosynthesis of stable, spherical SeNPs with a crystalline structure and an average diameter of ~56.8 nm, as confirmed by XRD, TEM, and UV–Vis spectroscopy (λmax = 236 nm). The SeNPs exhibited favorable colloidal stability (ZP = −22.47 mV) and broad-spectrum, dose-dependent antimicrobial activity against both Gram-positive and Gram-negative pathogens. Maximum inhibitory effects were observed at 64 µg/ml, underscoring their potent biocidal efficacy.
Conclusion
The biological technique employed in this study is appropriate for producing SeNPs with significant antibacterial properties against MDR pathogens and no toxicity to cell line tissue, provided that the product is homogeneous and the particle size is controlled.Keywords: Ralstonia mannitolilytica, selenium nanoparticles, inhibition zone
Zitieren
APA
Dahee, R. J., Hamid, M. K., & Ahmed, M. E. (2026). Biosynthesis of Selenium Nanoparticles by Ralstonia mannitolilytica and Evaluation of Their Antibacterial Activity. Iraqi Journal of Medical Sciences, 24(1), 89-99. https://doi.org/10.22578/d2qjma08
Vancouver
Dahee RJ, Hamid MK, Ahmed ME. Biosynthesis of Selenium Nanoparticles by Ralstonia mannitolilytica and Evaluation of Their Antibacterial Activity. Iraqi Journal of Medical Sciences. 2026;24(1):89-99. doi:10.22578/d2qjma08
BibTeX
@article{Dahee2026,
author = {Dahee, Rusul J. and Hamid, Mazin K. and Ahmed, Mais E.},
title = {Biosynthesis of Selenium Nanoparticles by Ralstonia mannitolilytica and Evaluation of Their Antibacterial Activity},
journal = {Iraqi Journal of Medical Sciences},
year = {2026},
volume = {24},
number = {1},
pages = {89--99},
doi = {10.22578/d2qjma08}
}
EUVIMED